Navigation Links
Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study

k following traumatic injuries beginning in the prehospital setting. Treatment began at the scene of injury, continued in the ambulance during transport, and for up to 12 hours post-injury or a total of 6 units. Patients then received donated blood if they continued to bleed. Patients in the control group received the standard of care: saline in the field and during transport, followed by blood upon arrival at the hospital. Thirty-two Level I trauma centers participated in the study, which was conducted to seek an indication for the use of PolyHeme that addresses a critical, unmet medical need: the unavailability of blood.

In December 2006, Northfield announced that it had received the preliminary draft top-line data from its contract research organization. Northfield indicated that due to certain discrepancies in the data identified during its initial review, it became necessary to resolve the discrepancies and unlock the study database to make any necessary corrections. The process has now been completed, the study database relocked, and the data reanalyzed. Northfield has also had the opportunity to further analyze the study data, including additional safety data. These data have not been submitted to or reviewed by FDA.

About Northfield Laboratories

Northfield Laboratories, Inc., is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is, therefore, compatible with all blood types. It has a shelf life in excess of 12 months. For further information, visit www.northfieldlabs.com.

Forward Looking Statement

This press release may contain forward-looking statements concerning, among other things, Northfield's future business plans and strategies and clinical and regulatory developments af
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Northfield Laboratories Investor Update
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
9. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
Post Your Comments:
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... market for Fluoroscopy is expected to grow at a ... is used to view the gastrointestinal tract, to direct ... ducts or the urinary system, to open narrowed or ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ) has ... - Global Strategic Business Report" report to ... are provided for the period 2014 through 2020. ... these markets. Market data and analytics are derived ... primarily based on public domain information including company ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2
... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ ... ingredients (APIs), announced that its,Tainan facility has received ... The Certification confirms ScinoPharm,s,competency and proficiency in the ... applies to specific laboratories and,production areas used for ...
... , CAMBRIDGE, Mass., Nov. 19 Ligon ... to find drugs against high-value targets, today announced that ... incTANK Ventures. The company will use the capital to ... 100 high-value disease protein targets. With this investment, incTANK ...
Cached Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3
(Date:6/2/2015)... (PRWEB) June 02, 2015 The 3TVPhoenix contest, ... to watch the station’s 6:00 a.m. Good Morning Arizona program ... on the station’s Facebook page. , Lisa Allen ... participants. She plans to apply the monthly $1,000 prize ... Allen, a stay-at-home mom, expressed her surprise and gratitude at ...
(Date:6/2/2015)... India (PRWEB) June 02, 2015 Bitscape ... in the 2015 Microsoft Worldwide Small and Midsized Cloud ... field of top Microsoft partners for demonstrating excellence in ... technology. , “This comes as no surprise to ... recognized third year consecutively at worldwide level by Microsoft. ...
(Date:6/2/2015)... HERSHEY, Pa. (PRWEB) June 02, 2015 ... honored as one of the 30 members of the ... State College of Medicine. He was presented with a ... field. , “We are extremely proud of Vincent’s ... Gurt ’85. “He is a great example of how ...
(Date:6/2/2015)... RI (PRWEB) June 02, 2015 ... equipment distributor, has announced the acquisition of ... equipment distributor, effective May 29th, 2015. , With CME’s ... 2015, this latest acquisition joins three premier organizations which ... to hospitals and healthcare facilities. By combining forces, they ...
(Date:6/2/2015)... Mo. (PRWEB) June 02, 2015 With a ... Senior Living & Health Care has hired Leslie Young ... expansion of human resource initiatives to better understand and respond ... families in Tutera’s 47 communities in 13 states across the ... highest levels of personalized support to our residents, we are ...
Breaking Medicine News(10 mins):Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4
... tremor, a very common movement disorder, increases in incidence ... While voice tremors are not uncommon, the condition can ... it.// ,Previous treatments for voice tremor, such ... and are primarily recommended for treating hand tremors. Researchers ...
... recent study shows a completely artificial heart could prevent ... candidates for a heart transplant . The artificial heart ... and after transplantation. // ,The artificial heart ... transplantation in many patients who did not improve with ...
... Breast cancer may be detected earlier using a computer-assisted ... study. CAD is a computer-based analysis designed to find ... that appear only as tiny white specks on mammography ... ,Researchers reviewed the cases of 519 patients ...
... Researchers are now saying that the gene known as “mighty ... Studies on this gene arose when a German neurologist , ... well-developed muscles. Further tests revealed the child had a mutation ... producing the myostatin protein, which is known to regulate muscle ...
... found to boost the immune system and help fight off ... on children already in the hospital with severe pneumonia// and ... children with severe pneumonia recover quicker . ,The study ... About half received 20 milligrams of zinc per day while ...
... loss of liver function that can cause death within ... supportive care intended to keep patients alive long enough ... donor organ becomes available for transplantation. About 80 percent ... transplant. ,A bioartificial liver along with pig stem ...
Cached Medicine News:
... The AQT-10 is the ultimate in ... designed to detect the subtle red/green or ... disorders as retinal toxicity (that from Plaquenil, ... retinopathy, and macular degeneration. Additionally it is ...
... Amplifier (UBA-4204) from LKC Technologies, ... amplification and complete electrical isolation ... problems of DC drifting, 50/60Hz ... make the amplifier ideal for ...
... PACHETT 3 uses the exact enhanced corneal ... DGH pachymeters used exclusively by the OHTS ... into the software. The new backlit LCD ... average, standard deviation and IOP correction calculation ...
Orbital Retractor, schepens Retractors, overall length:154mm....
Medicine Products: